Growth factor deprivation is a physiological mechanism to induce apoptosis. We used an IL-2-dependent murine T cell line to identify proteins that trigger apoptosis. Here we report the identi®cation, the cloning and characterization of ITM2B s , a protein induced upon IL-2-deprivation. ITM2B s , which shares the BH3 domain of Bcl-2 family members, is a cytoplasmic and mitochondrial protein. Expression of ITM2B s induces apoptosis in IL-2-stimulated cells, but not in IL-4-stimulated cells, while overexpression of the long form of the protein is not able to induce apoptosis. In IL-2-stimulated cells, ITM2B s interacts with the antiapoptotic protein Bcl-2, and does not interact with the proapoptotic Bad. Mutation of the critical L and D residues within the BH3 domain abolished the ability of ITM2B s to promote apoptosis.
Introduction
Members of the Bcl-2 family proteins are regulators of cell death that can be grouped into prosurvival and proapoptotic molecules (Adams and Cory, 1998; Gross et al., 1999) . They are characterized by the presence of several conserved motifs, known as the Bcl-2 homology (BH) domains, designed BH1, BH2, BH3 and BH4. Although the BH4 domain is restricted to some prosurvival members, BH1, BH2 and BH3 can generally be found among members of both, the prosurvival and the proapoptotic proteins. Mutagenesis and structural studies revealed that BH3 domain is important for dimerization function. In addition to its role as a protein ± protein interaction domain, the BH3 motif of proapoptotic members appears to be important for mediating their proapoptotic function (Chittenden et al., 1995b; Kelekar and Thompson, 1998) . This is supported by recent discovery of a new group of cell death members containing only the BH3 domain (Fesik, 2000) . BH3 domain in these molecules plays an important role in mediating proapoptotic function as well as association with the prosurvival members of the Bcl-2 family. It has been shown that mutagenesis of the critical leucine and aspartic acid residues within the BH3 domain of Bax is critical for dimerization and killing (Wang et al., 1998) .
Most of BH3-only proteins were discovered in protein interaction traps by binding to Bcl-2 or Bcl-x or in functional assays. The amphipathic helix formed by the BH3 domain of BH3-only proteins bind to a hydrophobic groove on the surface of the antiapoptotic Bcl-2 family members (Fesik, 2000) . Bid can also interact with Bax and Bak, resulting in cytochrome c releasing . This result suggests that some BH3-only proteins can promote apoptosis by two mechanisms: inactivating prosurvival Bcl-2-like proteins by direct binding or by modi®cation of proapoptotic Bax-like molecules.
Many BH3-only proteins are present in healthy cells in a dormant form and are activated by posttranslational modi®cations. Signals from certain growth factors results in phosphorylation of Bad at multiple sites and sequestration of modi®ed Bad by binding to 14-3-3 protein (Hsu et al., 1997; Zha et al., 1996b) . In addition to post-translational modi®cations, BH3-containing proteins may be regulated at the level of expression. Neuronal cell death upon deprivation of nerve growth factor can be blocked by inhibitors of RNA and protein synthesis, suggesting that this death is dependent on the regulated expression of some apoptotic factor(s) (Lutz, 2000) . Finally, an interferoninduced dual function protein with a BH3 domain can polymerize ATP and promote apoptosis independently (Ghosh et al., 2001) .
Integral membrane protein 2B (ITM2B) is a type II integral membrane protein that is associated to chrondrogenic dierentiation (Deleersnijder et al., 1996) . ITM2B belongs to a multiple gene family containing, at least, two other members, ITM2A and ITM2C. The three isoforms share 50% identity at the amino acid level, with most of the similarity in the COOH-terminal domain. An alternative splicing of ITM2B generates the long and short forms of ITM2B. In this manuscript we describe the characterization of ITM2B s as a novel regulator of cell death, that promotes apoptosis and interacts with Bcl-2.
Results

Identification of ITM2B s as an IL-2-deprivation induced gene in TS1ab cells
To identify proteins that could be involved in the induction of apoptosis, we performed a representational dierence analysis (RDA) of gene expression in IL-2-deprived cells. Cells were IL-2-stimulated or -deprived for 20 h before mRNA extraction. The isolation of IL-2-deprivation induced transcripts was performed using the representational dierence analysis technique as previously described (Hubank and Schatz, 1994; Louahed et al., 1999) . Oligo (dT)-primed cDNAs were synthesized, digested with DpnII and used to generate the respective amplicons. After three rounds of subtractive hybridization, the third product was cloned. Among the dierent IL-2-deprivation induced transcripts, one of these clones consisted of a 190 nucleotide DpnII fragment showing a 100% match to a cDNA encoding the integral membrane protein 2B (ITM2B). The kinetic of ITM2B expression was analysed by Northern blot after IL-2-deprivation for dierent periods of time. As shown in Figure 1 , a transcript of 1.1 kb corresponding to ITM2B s was upregulated within 3 h of IL-2-deprivation and maximal expression was reached upon 20 h of lymphokine deprivation. The upregulation of ITM2B s expression was also con®rmed using a probe of the 5' untranslated region of ITM2B s , that is absent in ITM2B L (data not shown). A non upregulated 1.4 kb transcript that corresponds to the long form of the protein, ITM2B L , was also observed (Figure 1 ). As internal control of RNA loaded, 28S and 18S signal are shown.
The full-length ITM2B s was cloned by PCR and encodes a 210 amino acid protein (Figure 2a) . Protein homology searches in the GenBank database with the Blast program revealed a stretch of six amino acids, 35 ± 40, with high homology to a BH3 motif ( Figure  2b ). This conserved motif is shared by Bcl-2 family members such as Bad, Bak, Bax, Bcl-x, Bcl-2, Bid, Bik, Bim, Harakiri, Noxa, Diva, Map1, 2-5(A) synthase and Puma ( Figure 2b ) (Chinttenden et al., 1995a; Zha et al., 1996a) . The mouse genomic database revealed a clone from chromosome 14 containing the ITM2B s gene. Comparison with the cDNA sequence suggests a ®ve exon structure (Figure 2c) for ITM2B s gene.
To study the eect of IL-2-deprivation on ITM2B s protein expression, cells were stimulated or deprived of IL-2 for dierent periods of time and total ITM2B s expression analysed by Western blot. Weak expression of ITM2B was observed in control IL-2-stimulated cells, increasing around threefold upon IL-2-deprivation (Figure 3a) . Reprobing the membrane with panRas showed similar level of Ras expression throughout the kinetic analysed. The speci®city of the generated ITM2B s antibody was estimated by competition with increasing concentrations of the peptide used for generation of the antibody (Figure 3b ). This antibody recognizes both ITM2B s and ITM2B L , that can be dierentiated by molecular weight. In addition, we also have generated polyclonal antibodies that speci®cally recognize ITM2B L . These results suggest that the dierent induction kinetics at the mRNA and protein level may be attributed to speci®c function acquired after IL-2-deprivation.
To determine the subcellular localization of ITM2B s , we isolated nuclear, mitochondrial, cytosolic and cytoplasmic proteins of IL-2-stimulated or -deprived cells. ITM2B s was detected by Western blot in cytoplasmic extracts of IL-2-stimulated or -deprived cells and was not observed in nuclear extracts of IL-2-stimulated or -deprived cells ( Figure  4) . ITM2B s was detected in the mitochondrial fraction of IL-2-stimulated cells. The amount of ITM2B s associated to mitochondria increased upon IL-2-deprivation. We were not able to detect ITM2B s in the cytosolic fraction of IL-2-stimulated cells, being weakly detected in cytosolic fraction of IL-2-deprived cells (Figure 4 ). As internal control of protein fractionation, the blot was probed with panRas (cytoplasmic marker), anti-caspase 3 (cytosolic marker), anti-Mito 2813 (pyruvate dehydrogenase, mitochondria marker) and anti-Histones antibody (nuclear marker). The BH3 domain of ITM2B s is required for the induction of apoptosis
To determine if the BH3 domain of ITM2B s is required to induce apoptosis, we compared the apoptotic activity of wild-type ITM2B s and a BH3 domain To determine the ability of ITM2B s to associate with antiapoptotic molecules, we performed immunoprecipitation experiments using ITM2B s and Bcl-2 speci®c antibodies. ITM2B s was detected by Western blot in anti-Bcl-2 immunoprecipitates of IL-2-stimulated cells and was not observed in anti-Bad immunoprecipitates (Figure 7a) . ITM2B s was not observed in anti-Bcl-2 or anti-Bad immunoprecipitates of IL-2-deprived cells. Reprobing the membrane with anti-Bcl-2 and anti-Bad antibodies showed both proteins in IL-2-stimulated cells and only Bad expression in IL-2-deprived cells. To con®rm the interaction, we performed reciprocal experiment, Bcl-2 was detected in anti-ITM2B s immunoprecipitates of IL-2-stimulated cells (Figure 7a ) and was not observed in anti-ITM2B immunoprecipitates of IL-2-deprived cells. We were not able to detect association of Bad to ITM2B s upon ITM2B immunoprecipitation (Figure 7a ). Reprobing the membrane with anti-ITM2B showed the presence of the protein. The speci®city of the described interaction was con®rmed by immunoprecipitation of cytoplasmic lysates with an irrelevant antibody, anti-IL-2. To study the eect of IL-2-deprivation in Bad and Bcl-2 expression, TS1ab cells were IL-2-stimulated or -deprived for dierent periods of time and total protein expression was analysed by Western blot. Expression of Bad was observed in IL-2-stimulated cells and not modi®ed throughout the starvation period (Figure 7b ). Bcl-2 expression was observed in IL-2-stimulated cells, decreasing throughout lymphokine deprivation (Figure 7b ).
Discussion
We have identi®ed ITM2B s as a novel regulator of cell death that induces apoptosis in T cells. ITM2B s shares homology with the BH3 domain of Bcl-2 family members, but lacks conserved BH1, BH2 and BH4 domain. BH3-only proteins may be regulated by distinct signals and they may also have dierent Figure 5 Expression of ITM2B s induces apoptosis, which is repressed by Bcl-2. (a) Cells were transfected with or without ITM2B s using the DEAE-dextran method and maintained after transfection with or without IL-2 for 20 h. Cells were washed, permeabilized and stained with propidium iodide. Samples were analysed by¯ow cytometry. Non transfected cells maintained in the presence or absence of IL-2 were also used as control. Standard deviation (s.d.) is shown were n=3. IL-2-stimulation, white bars; IL-2-deprivation, shaded bars. Expression of the transiently transfected ITM2B s was con®rmed by direct comparison of protein level in mock and ITM2B s transfected cells. The blot was probed with pan-Ras as internal control of protein loading. IL-2-stimulation, white bars; IL-2-deprivation, shaded bars. (b) Cells were transfected with or without ITM2B s as in a and maintained after transfection with or without IL-4 for 24 h. Samples were analysed by¯ow cytometry. Non transfected cells maintained in the presence or absence of IL-4 were also used as control. Standard deviation (s.d.) is shown were n=3. IL-4-stimulation, white bars; IL-4-deprivation, shaded bars. Expression of the transiently transfected ITM2B s was con®rmed by Western blot. The blot was proved with pan-Ras as internal control of protein loading. IL-4-stimulation, white bars; IL-4-deprivation, shaded bars. (c) Cells were cotransfected with or without ITM2B s or ITM2B s and Bcl-2 as in a and maintained after transfection in the presence or absence of IL-2 for 24 h. Samples were analysed by¯ow cytometry. Expression of the transfected ITM2B s was con®rmed by Western blot. The blot was probed with pan-Ras as internal control of protein loading. IL-2-stimulation, white bars; IL-2-deprivation, shaded bars. Similar results were obtained in three independent experiments eector functions. It has been described that BH3 domain of Bax and Bak is required for association to Bcl-2 and Bcl-x (Chinttenden et al., 1995a; Han et al., 1996; Simonain et al., 1996; Zha et al., 1996a) . In addition, deletion of BH3 domain blocks apoptotic activity of Bak, Bad and Noxa (Chittenden et al., 1995b; Oda et al., 2000) . Our results demonstrate and con®rm previous results showing that mutation of the critical amino acids leucine (L) and aspartic acid (D) within ITM2B s BH3 domain inhibits apoptotic activity. Thus, BH3 domain of ITM2B s appears to be critical for induction of apoptosis. Interestingly, Diva and Map1 are the only described proapoptotic members that lack one of the conserved residues of the BH3 domain.
ITM2B s interacts with Bcl-2, but not with Bad. Low level of Bcl-2/ITM2B s association was observed in IL-2-deprived cells because Bcl-2 was the limiting molecule Alternatively, cytoplasmic lysates from IL-2-stimulated or -deprived cells were immunoprecipitated with anti-Bcl-2 or anti-Bad antibodies, transferred to nitrocellulose and immunoblotted with anti-ITM2B, anti-Bcl-2 or anti-Bad, the two latter as internal control. Similar results were obtained in three independent experiments. As a negative control, cytoplasmic lysates from IL-2-stimulated or -deprived cells were immunoprecipitated with anti-IL-2 antibody and blotted with anti-ITM2B. (b) Cells were IL-2-stimulated or -deprived for dierent periods of time, then lysed. Protein extracts were separated by SDS ± PAGE, transferred to nitrocellulose and probed with anti-Bad, anti-Bcl-2 and pan-Ras, the latter as internal control of protein loading. Similar results were obtained in three independent experiments in the formation of the complex. Western blot of total extracts from IL-2-deprived cells con®rmed the downregulation of Bcl-2, but not ITM2B s , expression. Some BH3-only proteins can promote apoptosis by two mechanisms: inactivating prosurvival Bcl-2 proteins or modifying proapoptotic molecules. ITM2B s could induce apoptosis by inhibiting the antiapoptotic activity of Bcl-2. Alternatively, ITM2B s may be a protein with apoptotic activity and Bcl-2 may serve as inhibitor. As IL-2-deprived cells downregulate Bcl-2 expression, there is no inhibitor of ITM2B s activity. In agreement, overexpression of Bcl-2 blocks apoptotic activity of ITM2B s . The function of apoptotic Bcl-2 members may be regulated by binding to antiapoptotic members, inhibiting activation of caspases. Besides interaction with sequestering proteins, the activity of apoptotic Bcl-2 family proteins can be suppressed by other mechanisms, including post-translational modi®cations. For example, Bad protein is inactivated by phosphorylation (Datta et al., 1997; Del Peso et al., 1997) . Other post-translational modi®cation that activates proapoptotic proteins is proteolysis. Bid is N-myristoylated when cleaved by caspase 8 and this postproteolytic N-myristoylation enhances apoptosis and release of cytochrome c (Zha et al., 2000) .
ITM2B resides on mouse chromosome 14. It is interesting to note that other proapoptotic molecules also localize in chromosome 14, some of them in the same locus; BNIP32 (Bcl-2 adenovirus E1B), which contains a BH3-domain and induces apoptosis; CIDEB (cell death inducing eector), that induces apoptosis by DNA damage; PTK2B, which induces apoptosis in ®broblast; the tumour suppressor Fhit; UBE1C (ubiquitin-activating enzyme E1C); VDAC2 (voltage dependent anion channel), which is involved in calcium release and DNAse 1L3, that is involved in cleavage of DNA. It is interesting to notice that the mRNA and protein level of ITM2B s are upregulated in TS1ab cells induced to undergo apoptosis by IL-2 deprivation. Low quantity of mRNA and protein are synthesized in IL-2-stimulated cells. This quantity of ITM2B s is presumably not enough to induce apoptosis. The mRNA level of ITM2B L is not upregulated upon IL-2 deprivation. Moreover, expression of ITM2B L is not able to induce apoptosis. It is interesting to note that the N-terminal 57 amino acid of ITM2B L contains a binding motif for IAPs (inhibitory apoptosis protein). It is tempting to speculate that IAPs are associated to the N-terminal region of ITM2B L , avoiding its proapoptotic role.
Some BH3-only regulators of apoptosis are constitutively expressed in cells and their apoptotic function is usually triggered by other events. ITM2B s synthesis is regulated by alternative splicing. Alternative splicing aecting the properties of apoptotic proteins is well documented in the case of Bcl-x protein. Bcl-x L and Bcl-x s are encoded by two alternatively spliced mRNAs. Bcl-x L is antiapoptotic and Bcl-x s is proapoptotic (Boise et al., 1993) . Alternative splicing aects the apoptotic properties of ITM2B; ITM2B s acts as a proapoptotic protein whereas ITM2B L does not induce apoptosis in IL-2-stimulated cells. In addition, ITM2B s is not able to induce apoptosis in IL-4-stimulated cells, indicating that the observed apoptotic eect of ITM2B s in IL-2-stimulated or -deprived cells is physiologically relevant and that the mechanisms that control apoptosis via IL-2R and IL-4R are dierent, as it has been previously shown (Cerezo et al., 1998 (Cerezo et al., , 1999 Rebollo et al., 2000) . The results presented here show a new role for ITM2B s as an apoptotic-associated gene with a BH3 domain that appears upon IL-2-deprivation, a stimulus that trigger apoptosis.
Materials and methods
Cells, lymphokines, antibodies and reagents
The murine T cell line TS1ab can be propagated independently in IL-2, IL-4 or IL-9 (Pitton et al., 1993) . Cells were cultured in RPMI-1640 supplemented with 5% heat-inactivated foetal calf serum, 2 mM glutamine, 10 mM HEPES, 0.55 mM arginine, 0.24 mM asparagine, 50 mM 2-ME and 5 ng/ml of IL-2 or 60 U/ml of IL-4. Murine rIL-4 or supernatant of a HeLa subline transfected with pKCRIL-4.neo was used as a source of murine IL-4. The QuikChange site-directed mutagenesis kit was from Stratagene (La Jolla, CA, USA). Trizol reagent and MessageMaker were from Life Technologies (Gaitersburg, MD, USA).
Representational difference analysis (RDA)
Total RNA was prepared from IL-2-stimulated or -deprived TS1ab cells using TRIZOL Reagent. Polyadenylated RNA was puri®ed from total RNA with oligo (dT) cellulose columns (GIBCO ± BRL). Double-stranded cDNA was generated from 5 mg poly (A) + RNA using an oligo (dT) primer and the SuperScript Choice System for cDNA synthesis, according to the manufacturer's recommendations (Life Technologies). Representational dierence analysis was performed as described (Hubank and Schatz, 1994; Louahed et al., 1999) . After three rounds of subtraction, ®nal dierence products were digested with DpnII and cloned into the BamHI site of pTZ19R. Double-stranded plasmid DNA was prepared and sequenced on both strands with an automatic sequencer. Sequence comparisons with the GenBank Database number were performed with the Blast search program. Quanti®cation of Western blot was made using the program Quantity One version 4.2.0 (BioRad).
RNA isolation
Total RNA was isolated using Trizol reagent according to the manufacturer's recommendations. For Northern blot analysis, 15 mg of RNA sample were electrophoresed in a 1% agarose gel in the presence of formaldehyde and transferred to nitrocellulose ®lter. After hybridization with the 32 P labelled probe, the ®lter was washed and exposed to X-ray ®lm at 7708C with intensifying screen.
Cloning of ITM2B s
According to the published sequence (AB030204), ITM2B s was cloned by PCR using the following primers: 5'-TTT TGT CGA CGC CGC CAT GTG TTT CGG ACT GGC CTT CAT G and 3'-TTT TGC GGC CGC TCA AGA ACA AAT TAA AGT CTC CAC AGC. Ampli®ed DNA of the correct size was con®rmed by sequencing and then cloned in the pCIneo expression vector.
Peptide synthesis and antibody production
A peptide of ITM2B s spanning amino acid sequence 39 ± 55 was synthesized on an automated multiple peptide synthesizer using the solid phase procedure and standard Fmoc chemistry. Purity and peptide composition were con®rmed in reverse-phase HPLC and by amino acid analysis. The peptide, glutaraldehyde-coupled to KLH via N-terminal was injected into outbred New Zealand rabbits. Sera were collected 7 ± 10 days after the last injection. This antibody recognizes both ITM2B s and ITM2B L that can be dierentiated by molecular weight. We also have generated polyclonal antibodies that speci®cally recognize ITM2B L .
Cell cycle analysis, transient transfection, immunoprecipitation and Western blot
Transient transfections, immunoprecipitations and Western blot were made as previously described in Romero et al., 1999 .
Site-directed mutagenesis
Site-directed mutagenesis was performed using the QuikChange mutagenesis kit. The primers used for mutation were: ITM2B s * 5': GTG TAC TAC TGT GGA GAA AAG TAC ATC AAA GCT GAC ATC CTG; ITM2B s * 3': CAG GAT GAC GTC AGC TTT GAT GTA CTT TTC TCC ACA GTA GTA CAC. The critical leucine (L) and aspartic acid (D) from the BH3 domain were mutated to glutamic acid (E) and alanine (A) respectively. Point mutations are in bold and underlined. Mutated ITM2B s sequence was con®rmed by sequencing.
Nuclear extracts
IL-2-stimulated or -deprived cells (3610 7 ) were resuspended for 2 min in 1 ml of buer A (50 mM NaCl, 10 mM HEPES pH 8, 0.5 M sucrose, 1 mM EDTA, 0.5 mM spermidine, 0.15 mM spermine and 0.2% Triton X-100). Lysates were centrifuged (4500 g, 23 min, 48C). Nuclei were resuspended in 1 ml buer B (50 mM NaCl, 10 mM HEPES, pH 8, 25% glycerol, 0.1 mM EDTA, 0.5 mM spermidine and 0.15 mM spermine) and centrifuged (4500 g, 3 min, 48C). Nuclear proteins were extracted at 48C for 30 min in 60 ml of buer C (350 mM NaCl, 10 mM HEPES, pH 8, 25% glycerol, 0.1 mM EDTA, 0.5 mM spermidine and 0.15 mM spermine). Supernatants were cleared by centrifugation and stored at 7808C. All buers were supplemented with protease inhibitors.
Isolation of mitochondria and S100 fraction
Mitochondria were isolated using a modi®cation of Yang et al. (1997) . Brie¯y, 20610 6 cells were IL-2-stimulated or -deprived, harvested and washed with ice-cold PBS. Cell pellet was suspended in 5 volumes of ice-cold buer A (20 mM HEPES KOH pH 7.5, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 0.1 mM PMSF and 250 mM sucrose) supplemented with protease inhibitors. Cells were disrupted in a Dounce homogenizer, the nuclei centrifuged (1000 g, 10 min, 48C) and the supernatant further centrifuged (10 000 g, 15 min, 48C). The resulting mitochondrial pellet was resuspended in buer A and stored at 7808C. The supernatant was centrifuged (100 000 g, 1 h, 48C) and the resulting S100 fraction stored at 7808C.
